HOME >> BIOLOGY >> NEWS
Light sticks may lure turtles to fishing lines

les are endangered species. A recent estimate published in the journal Ecology Letters suggests 200,000 loggerhead and 50,000 leatherback turtles may die each year in commercial fishery longlines. Total populations have declined in the past 20 years, Lohmann said.

While its difficult to separate the impact of longline fisheries from other threats turtles face, researchers say that the loss to longlines is significant because the turtles caught are often adolescents, which die before they have a chance to reproduce. Only about one in 5,000 turtles ever survive to adulthood. In the past, those lucky enough to last a few years in the ocean could expect a long life and would replenish the population. With the advent of longline fishing, the number of survivors has dwindled. A lot of turtles that beat the odds and would otherwise have lived long lives are now being caught on longlines, Lohmann said.

Lohmann, Wang and their team tested loggerhead turtles response to light sticks in a large, water-filled tank. Turtles were placed into a soft cloth harness and tethered to an electronic tracking device that monitored their movements. Safely encased in the soft fabric and released in the tank, the turtles swam as if in the open ocean, apparently unaware that they arent going anywhere, Wang said.

When glowing light sticks were introduced to the tank, the turtles swam toward them, as if curious about the lights, Lohmann said. The color or type of the light stick did not seem to matter. The turtles paddled toward green, blue and yellow light sticks, as well as toward both plastic chemical lightsticks and newer models based on reusable LEDs.

Both captive-raised and wild-caught juvenile turtles were attracted to glowing light sticks, whether in total darkness or underneath a night sky, Wang said. When the lights werent activated, they were unappealing. The experiments were conducted at the National Marine Fisheries Services Galveston Labora
'"/>

Contact: Becky Oskin
becky_oskin@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
4-May-2007


Page: 1 2 3

Related biology news :

1. Light-activated therapy targets DNA components
2. Light-activated compound silences nerves, may one day help epileptics
3. Lighting up life: Cold Spring Harbor Protocols presents tips for creating glowing plants
4. Light-Activated Tissue Regeneration and Therapy -- II
5. Lighting up the heart
6. Light guides flight of migratory birds
7. Light-to-moderate prenatal alcohol exposure can lead to cognitive deficits 10 years later
8. Light activated anticancer drug targeted to DNA using cisplatin like sub-units
9. Light-sensing cells in retina develop before vision
10. Light exercise a tonic to keep the brain young
11. Light-induced hormone surge points to benefits of light therapy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Light sticks may lure turtles fishing lines

(Date:11/21/2014)... , Nov. 20, 2014 Strict laws ... efficiency are piloting the North American and European automotive ... accidents growing, gesture recognition systems that are intuitive and ... mark in the industry. New analysis ... Gesture Recognition Market in Europe ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
(Date:12/15/2014)...  Ascendis Pharma A/S, a biotechnology company that ... unmet medical needs, today announced positive six-month interim ... to evaluate once-weekly TransCon Growth Hormone in children ... analysis consists of 25 patients, representing approximately 50% ... completing all six months of treatment. ...
(Date:12/13/2014)... The DNA Microarray market market was ... expected to grow at a CAGR of 15.2% ... TOC of the DNA Microarray for an in-depth ... help of various tables and figures. , ... consists of instrument, consumables, and services, where the ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4
Cached News: